Latest Insider Transactions at Vera Therapeutics, Inc. (VERA)
This section provides a real-time view of insider transactions for Vera Therapeutics, Inc. (VERA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vera Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vera Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2022
|
Joanne Curley Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,666
+6.31%
|
$93,996
$6.76 P/Share
|
|
Sep 13
2022
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
22,363
-5.81%
|
$469,623
$21.13 P/Share
|
|
Sep 13
2022
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,363
+5.49%
|
$44,726
$2.9 P/Share
|
|
Sep 12
2022
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
16,136
-4.2%
|
$322,720
$20.8 P/Share
|
|
Sep 12
2022
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,136
+3.98%
|
$32,272
$2.9 P/Share
|
|
Sep 09
2022
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
12,886
-6.64%
|
$257,720
$20.16 P/Share
|
|
Sep 09
2022
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,886
+6.23%
|
$25,772
$2.9 P/Share
|
|
Sep 08
2022
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
15,106
-7.7%
|
$302,120
$20.52 P/Share
|
|
Sep 08
2022
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,106
+7.15%
|
$30,212
$2.9 P/Share
|
|
Sep 07
2022
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
6,785
-3.61%
|
$135,700
$20.03 P/Share
|
|
Sep 07
2022
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,785
+3.48%
|
$13,570
$2.9 P/Share
|
|
Sep 07
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
988
-3.32%
|
$17,784
$18.63 P/Share
|
|
Sep 02
2022
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
17,096
-4.5%
|
$341,920
$20.88 P/Share
|
|
Sep 02
2022
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,096
+4.31%
|
$34,192
$2.9 P/Share
|
|
Sep 01
2022
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
17,100
-8.63%
|
$359,100
$21.22 P/Share
|
|
Sep 01
2022
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,100
+7.94%
|
$34,200
$2.9 P/Share
|
|
Aug 22
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,630
-2.66%
|
$30,970
$19.04 P/Share
|
|
Aug 22
2022
|
Joanne Curley Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,630
+2.59%
|
$17,930
$11.0 P/Share
|
|
Aug 19
2022
|
Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+48.16%
|
-
|
|
Aug 19
2022
|
Celia Lin Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+50.0%
|
-
|
|
Aug 19
2022
|
Sean Grant CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
33,750
+48.9%
|
-
|
|
Aug 19
2022
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
43,750
+19.45%
|
-
|
|
Aug 19
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
6,909
-3.66%
|
$131,271
$19.31 P/Share
|
|
Aug 19
2022
|
Joanne Curley Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,909
+3.48%
|
$41,454
$6.76 P/Share
|
|
Aug 19
2022
|
Joanne Curley Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+29.56%
|
-
|
|
Aug 17
2022
|
Carlyle Group Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
9,925
-0.11%
|
$198,500
$20.46 P/Share
|
|
Aug 17
2022
|
Carlyle Group Inc. > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Indirect |
9,925
+0.33%
|
$109,175
$11.0 P/Share
|
|
Aug 12
2022
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
20,528
-13.0%
|
$410,560
$20.16 P/Share
|
|
Aug 12
2022
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,528
+11.5%
|
$41,056
$2.9 P/Share
|
|
Aug 03
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
988
-5.41%
|
$15,808
$16.81 P/Share
|
|
Jul 19
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
11,444
-11.92%
|
$183,104
$16.28 P/Share
|
|
Jul 19
2022
|
Joanne Curley Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,444
+9.63%
|
$45,776
$4.64 P/Share
|
|
Jul 14
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
9,104
-18.15%
|
$136,560
$15.15 P/Share
|
|
Jul 14
2022
|
Joanne Curley Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,354
+18.84%
|
$12,708
$2.9 P/Share
|
|
Jul 07
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
9,666
-12.33%
|
$144,990
$15.05 P/Share
|
|
Jul 07
2022
|
Joanne Curley Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,001
+11.41%
|
$28,004
$4.64 P/Share
|
|
Jun 22
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,545
-3.09%
|
$23,175
$15.02 P/Share
|
|
Jun 22
2022
|
Joanne Curley Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,239
+4.68%
|
$7,434
$6.37 P/Share
|
|
Jun 17
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,887
-7.18%
|
$88,305
$15.05 P/Share
|
|
Jun 17
2022
|
Joanne Curley Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,687
+7.65%
|
$18,748
$4.64 P/Share
|
|
Jun 15
2022
|
Sean Grant CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Indirect |
5,000
+50.0%
|
$65,000
$13.6 P/Share
|
|
May 31
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
400
-1.56%
|
$6,000
$15.22 P/Share
|
|
May 31
2022
|
Joanne Curley Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+1.54%
|
$2,400
$6.37 P/Share
|
|
Feb 10
2022
|
Patrick G Enright |
BUY
Open market or private purchase
|
Indirect |
333,333
+8.86%
|
$4,999,995
$15.0 P/Share
|
|
Feb 10
2022
|
Longitude Capital Partners Iv, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
333,333
+8.86%
|
$4,999,995
$15.0 P/Share
|
|
Feb 10
2022
|
Sofinnova Venture Partners X, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
266,666
+7.73%
|
$3,999,990
$15.0 P/Share
|
|
Feb 06
2022
|
Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR |
BUY
Open market or private purchase
|
Direct |
5,714
+20.12%
|
$39,998
$7.0 P/Share
|
|
Feb 06
2022
|
Sean Grant CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
14,285
+22.24%
|
$99,995
$7.0 P/Share
|
|
May 18
2021
|
Andrew Cheng |
BUY
Conversion of derivative security
|
Indirect |
17,488
+50.0%
|
-
|
|
May 18
2021
|
Patrick G Enright |
BUY
Open market or private purchase
|
Indirect |
909,090
+22.7%
|
$9,999,990
$11.0 P/Share
|